
Healthequity Inc
NASDAQ:HQY

Intrinsic Value
The intrinsic value of one
HQY
stock under the Base Case scenario is
91.46
USD.
Compared to the current market price of 97.6 USD,
Healthequity Inc
is
Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Healthequity Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Healthequity Inc
Balance Sheet Decomposition
Healthequity Inc
Current Assets | 477.7m |
Cash & Short-Term Investments | 295.9m |
Receivables | 118m |
Other Current Assets | 63.8m |
Non-Current Assets | 3B |
PP&E | 46.4m |
Intangibles | 2.9B |
Other Non-Current Assets | 71.6m |
Free Cash Flow Analysis
Healthequity Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Healthequity Inc
Revenue
|
1.2B
USD
|
Cost of Revenue
|
-422.5m
USD
|
Gross Profit
|
777.3m
USD
|
Operating Expenses
|
-574.4m
USD
|
Operating Income
|
202.9m
USD
|
Other Expenses
|
-106.2m
USD
|
Net Income
|
96.7m
USD
|
HQY Profitability Score
Profitability Due Diligence
Healthequity Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Healthequity Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
HQY Solvency Score
Solvency Due Diligence
Healthequity Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Score
Healthequity Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HQY Price Targets Summary
Healthequity Inc
According to Wall Street analysts, the average 1-year price target for
HQY
is 114 USD
with a low forecast of 94.94 USD and a high forecast of 136.5 USD.
Dividends
Current shareholder yield for HQY is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HQY
stock under the Base Case scenario is
91.46
USD.
Compared to the current market price of 97.6 USD,
Healthequity Inc
is
Overvalued by 6%.